Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Do I hear $1.40's

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Nov 18, 2021 1:02pm

100 Views

Post# 34141573

RE:Do I hear $1.40's

Thomvest just loving this action. Tell management to shelve all 4050 indications, delay any reporting on phase 1 MAD study and stop any quarterly conference calls. Take private - sell or license 4050 in 3 years to Boehringher from some Canary Islands numbered company.